Cannabis Ruderalis

    Add links
    5F-NNE1 structure.png
    Legal status
    Legal status
    • 1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide
    CAS Number
    PubChem CID
    Chemical and physical data
    Molar mass374.459 g·mol−1
    3D model (JSmol)
    • FCCCCCn1cc(c2c1cccc2)C(=O)Nc1cccc2c1cccc2
    • InChI=1S/C24H23FN2O/c25-15-6-1-7-16-27-17-21(20-12-4-5-14-23(20)27)24(28)26-22-13-8-10-18-9-2-3-11-19(18)22/h2-5,8-14,17H,1,6-7,15-16H2,(H,26,28)

    5F-NNE1 (also known as 5F-NNEI and 5F-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-NNE1 may release 1-naphthylamine, a known carcinogen.


    Sweden's public health agency suggested classifying 5F-NNE1 as hazardous substance on November 10, 2014.[3]

    See also[edit]


    1. ^ "5F-NNEI". Southern Association of Forensic Scientists. Archived from the original on 27 May 2015. Retrieved 24 July 2015.
    2. ^ Wohlfarth A, Castaneto MS, Zhu M, Pang S, Scheidweiler KB, Kronstrand R, Huestis MA (May 2015). "Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA". The AAPS Journal. 17 (3): 660–77. doi:10.1208/s12248-015-9721-0. PMC 4406957. PMID 25721194.
    3. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.

    Leave a Reply